THIAZOLO(4,5-C)QUINOLINES
The invention relates to new thiazolo[4,5-c]quinoline derivatives of the general Formula I (I) and acid addition salts thereof, a process for the preparation of the same and pharmaceutical compositions comprising the said compounds. The substituent definition of the general Formula I is as follows:...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | BERTA KNOLL ILDIKO NIKLYA GABRIELLA ZSILA ATTILA MANDI EDIT BERENYI JULIA TIMAR LUJZA PETOCZ KATALIN BUDAI ZSUZSA FURTS JOZSEF KNOLL |
description | The invention relates to new thiazolo[4,5-c]quinoline derivatives of the general Formula I (I) and acid addition salts thereof, a process for the preparation of the same and pharmaceutical compositions comprising the said compounds. The substituent definition of the general Formula I is as follows: R stands for hydrogen; a straight or branched chained alkyl group having 2-5 carbon atoms optionally substituted by one or more halogen atom(s); phenyl or phenyl-(lower alkyl) optionally bearing one or more substituent(s) on the phenyl ring; R1 and R2 are identical or different and stand for hydrogen, halogen or lower alkyl). The compounds of the general Formula I possess valuable central nervous depressive properties. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU6508986A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU6508986A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU6508986A3</originalsourceid><addsrcrecordid>eNrjZJAM8fB0jPL38dcw0THVddYMDPX08_fx9HMN5mFgTUvMKU7lhdLcDPJuriHOHrqpBfnxqcUFicmpeakl8Y6hZqYGFpYWZo7GhFUAAIpLHyE</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>THIAZOLO(4,5-C)QUINOLINES</title><source>esp@cenet</source><creator>BERTA KNOLL ; ILDIKO NIKLYA ; GABRIELLA ZSILA ; ATTILA MANDI ; EDIT BERENYI ; JULIA TIMAR ; LUJZA PETOCZ ; KATALIN BUDAI ; ZSUZSA FURTS ; JOZSEF KNOLL</creator><creatorcontrib>BERTA KNOLL ; ILDIKO NIKLYA ; GABRIELLA ZSILA ; ATTILA MANDI ; EDIT BERENYI ; JULIA TIMAR ; LUJZA PETOCZ ; KATALIN BUDAI ; ZSUZSA FURTS ; JOZSEF KNOLL</creatorcontrib><description>The invention relates to new thiazolo[4,5-c]quinoline derivatives of the general Formula I (I) and acid addition salts thereof, a process for the preparation of the same and pharmaceutical compositions comprising the said compounds. The substituent definition of the general Formula I is as follows: R stands for hydrogen; a straight or branched chained alkyl group having 2-5 carbon atoms optionally substituted by one or more halogen atom(s); phenyl or phenyl-(lower alkyl) optionally bearing one or more substituent(s) on the phenyl ring; R1 and R2 are identical or different and stand for hydrogen, halogen or lower alkyl). The compounds of the general Formula I possess valuable central nervous depressive properties.</description><edition>4</edition><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>1987</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19870514&DB=EPODOC&CC=AU&NR=6508986A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19870514&DB=EPODOC&CC=AU&NR=6508986A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>BERTA KNOLL</creatorcontrib><creatorcontrib>ILDIKO NIKLYA</creatorcontrib><creatorcontrib>GABRIELLA ZSILA</creatorcontrib><creatorcontrib>ATTILA MANDI</creatorcontrib><creatorcontrib>EDIT BERENYI</creatorcontrib><creatorcontrib>JULIA TIMAR</creatorcontrib><creatorcontrib>LUJZA PETOCZ</creatorcontrib><creatorcontrib>KATALIN BUDAI</creatorcontrib><creatorcontrib>ZSUZSA FURTS</creatorcontrib><creatorcontrib>JOZSEF KNOLL</creatorcontrib><title>THIAZOLO(4,5-C)QUINOLINES</title><description>The invention relates to new thiazolo[4,5-c]quinoline derivatives of the general Formula I (I) and acid addition salts thereof, a process for the preparation of the same and pharmaceutical compositions comprising the said compounds. The substituent definition of the general Formula I is as follows: R stands for hydrogen; a straight or branched chained alkyl group having 2-5 carbon atoms optionally substituted by one or more halogen atom(s); phenyl or phenyl-(lower alkyl) optionally bearing one or more substituent(s) on the phenyl ring; R1 and R2 are identical or different and stand for hydrogen, halogen or lower alkyl). The compounds of the general Formula I possess valuable central nervous depressive properties.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1987</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJAM8fB0jPL38dcw0THVddYMDPX08_fx9HMN5mFgTUvMKU7lhdLcDPJuriHOHrqpBfnxqcUFicmpeakl8Y6hZqYGFpYWZo7GhFUAAIpLHyE</recordid><startdate>19870514</startdate><enddate>19870514</enddate><creator>BERTA KNOLL</creator><creator>ILDIKO NIKLYA</creator><creator>GABRIELLA ZSILA</creator><creator>ATTILA MANDI</creator><creator>EDIT BERENYI</creator><creator>JULIA TIMAR</creator><creator>LUJZA PETOCZ</creator><creator>KATALIN BUDAI</creator><creator>ZSUZSA FURTS</creator><creator>JOZSEF KNOLL</creator><scope>EVB</scope></search><sort><creationdate>19870514</creationdate><title>THIAZOLO(4,5-C)QUINOLINES</title><author>BERTA KNOLL ; ILDIKO NIKLYA ; GABRIELLA ZSILA ; ATTILA MANDI ; EDIT BERENYI ; JULIA TIMAR ; LUJZA PETOCZ ; KATALIN BUDAI ; ZSUZSA FURTS ; JOZSEF KNOLL</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU6508986A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>1987</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>BERTA KNOLL</creatorcontrib><creatorcontrib>ILDIKO NIKLYA</creatorcontrib><creatorcontrib>GABRIELLA ZSILA</creatorcontrib><creatorcontrib>ATTILA MANDI</creatorcontrib><creatorcontrib>EDIT BERENYI</creatorcontrib><creatorcontrib>JULIA TIMAR</creatorcontrib><creatorcontrib>LUJZA PETOCZ</creatorcontrib><creatorcontrib>KATALIN BUDAI</creatorcontrib><creatorcontrib>ZSUZSA FURTS</creatorcontrib><creatorcontrib>JOZSEF KNOLL</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>BERTA KNOLL</au><au>ILDIKO NIKLYA</au><au>GABRIELLA ZSILA</au><au>ATTILA MANDI</au><au>EDIT BERENYI</au><au>JULIA TIMAR</au><au>LUJZA PETOCZ</au><au>KATALIN BUDAI</au><au>ZSUZSA FURTS</au><au>JOZSEF KNOLL</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>THIAZOLO(4,5-C)QUINOLINES</title><date>1987-05-14</date><risdate>1987</risdate><abstract>The invention relates to new thiazolo[4,5-c]quinoline derivatives of the general Formula I (I) and acid addition salts thereof, a process for the preparation of the same and pharmaceutical compositions comprising the said compounds. The substituent definition of the general Formula I is as follows: R stands for hydrogen; a straight or branched chained alkyl group having 2-5 carbon atoms optionally substituted by one or more halogen atom(s); phenyl or phenyl-(lower alkyl) optionally bearing one or more substituent(s) on the phenyl ring; R1 and R2 are identical or different and stand for hydrogen, halogen or lower alkyl). The compounds of the general Formula I possess valuable central nervous depressive properties.</abstract><edition>4</edition><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_epo_espacenet_AU6508986A |
source | esp@cenet |
subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | THIAZOLO(4,5-C)QUINOLINES |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T09%3A20%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=BERTA%20KNOLL&rft.date=1987-05-14&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU6508986A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |